1. Home
  2. NVAX vs MANE Comparison

NVAX vs MANE Comparison

Compare NVAX & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$9.58

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

MANE

Veradermics Incorporated Common Stock

N/A

Current Price

$59.18

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NVAX
MANE
Founded
1987
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NVAX
MANE
Price
$9.58
$59.18
Analyst Decision
Hold
Strong Buy
Analyst Count
9
4
Target Price
$11.33
$78.33
AVG Volume (30 Days)
4.4M
273.3K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
309.76
N/A
EPS
2.58
N/A
Revenue
$1,123,479,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.77
N/A
Revenue Growth
64.69
N/A
52 Week Low
$5.01
$36.26
52 Week High
$11.85
$63.03

Technical Indicators

Market Signals
Indicator
NVAX
MANE
Relative Strength Index (RSI) 46.76 71.72
Support Level $9.14 $39.73
Resistance Level $10.42 $63.03
Average True Range (ATR) 0.60 4.27
MACD -0.13 0.76
Stochastic Oscillator 16.52 79.50

Price Performance

Historical Comparison
NVAX
MANE

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

About MANE Veradermics Incorporated Common Stock

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

Share on Social Networks: